Chemring Group's order book tells the story of why the FTSE 250 defence technology company is in demand. In its interim results published on 2 June 2026, covering the six months to 30 April, the group reported a record order book of £1,399.4m, up 8% and the highest in its history. Revenue from continuing operations rose 7% to £237.3m.

Demand has been particularly strong in Countermeasures & Energetics, against a backdrop of geopolitical instability, a shift towards high-intensity deterrence and higher defence spending. At 30 April, 91% of the group's expected 2026 revenue had already been delivered or was in the order book, and the Board's expectations for the full year were unchanged.

Strong Demand has not yet translated into higher profits, however. Underlying operating profit fell 8% to £24.5m, the company flagged near-term disruption in the UK market and it is investing heavily in capacity, while Leadership is set to change with a new chief executive taking over at the start of 2027.

Two divisions serving defence customers

Chemring (LSE:CHG) operates through two main areas. Countermeasures & Energetics produces propellants, energetic materials and countermeasures, the consumable products that armed forces rely on and must replenish as they are used or as stockpile policies change. Sensors & Information includes Roke, which has recently begun selling a new counter-drone system.

The group's financial year ends on 31 October. Its Alloy Surfaces Business is being reported as a discontinued operation, so headline interim figures relate to continuing operations. The company also completed the Acquisition of Landguard Systems in June 2025.

Order momentum versus Margin pressure

Beyond the record order book and revenue growth, the interim profit picture was more mixed. Underlying EBITDA slipped 2% to £38.2m, and underlying operating profit fell 8% to £24.5m, giving a margin of 10.3%. Underlying Diluted Earnings per Share declined 8% to 6.1p, while statutory operating profit fell 25% to £21.7m.

The context from the previous year helps explain the direction of travel. In a post-close update on 10 November 2025, Chemring said FY25 adjusted operating profit was in line with analyst expectations, with a margin of about 14.7% compared with 14.2% in FY24. Energetics had performed more strongly than expected on demand for propellants, energetic materials and high-integrity devices as customers re-evaluated usage and stockpiles. Sensors & Information, by contrast, was soft because of delayed UK Government orders. The order book stood at £1.3bn at 31 October 2025, up from £1.0bn a year earlier.

Building energetics capacity

Much of Chemring's current Investment is directed at expanding Energetics production. The company said its Chicago expansion is complete and ramping up, its Scotland Facility is being commissioned, and the next phase in Norway is to follow. Capital Expenditure in the first half was £44m.

That investment has increased borrowing. Net Debt rose to £144.5m from £93.3m at the same point in 2025, taking net debt to EBITDA to 1.47x from 0.98x. The company attributed the increase to its Energetics investment, which is designed to meet the sustained demand it is seeing from customers.

Despite the heavier spending, the Board raised the Interim Dividend by 4% to 2.8p.

Contracts, counter-drone sales and a new chief executive

Recent announcements point to activity across the business. On 1 July 2026, US Subsidiary Chemring Sensors & Electronic Systems was awarded a sole-source, three-year indefinite delivery, indefinite quantity (IDIQ) Full Rate Production contract for the Joint Biological Tactical Detection System (JBTDS), which detects and identifies airborne biological warfare agents. The contract has a ceiling of $48.8m and estimated completion in June 2029, with an initial production contract of $36.3m running through March 2028. The work will be carried out in Charlotte, North Carolina.

At Roke, the company reported early domestic and international sales of its new counter-drone system. Chemring (LSE:CHG) also announced contract awards for Alloy Surfaces on 25 June 2026 and a new Chair for Chemring Nobel on 30 June 2026.

On 30 July 2026, the group announced that chief executive Michael Ord will retire. His successor, Tom Newman, spent 17 years at Babcock International, most recently as chief executive of Babcock's Land and UK Aviation Sector, a business with revenue of around £1bn. Newman joins Chemring as Group CEO Designate on 5 October 2026 and will become Group CEO and join the Board on 1 January 2027, when Ord retires.

Risks on the radar

The interim numbers highlight a gap between orders and profitability. Margins fell to 10.3% in the first half from the roughly 14.7% achieved in FY25, and the company flagged near-term disruption in the UK market. Sensors & Information has previously been affected by delayed UK Government orders, showing how procurement timing can weigh on results.

Higher Leverage is another consideration. Net debt to EBITDA has risen to 1.47x, and capacity projects in Scotland and Norway still need to be brought fully on stream. Delays or cost overruns in such projects could affect returns on the investment.

Leadership transition also carries some execution risk, as a new chief executive takes over during a period of expansion. More broadly, defence demand is shaped by government budgets and policy, which can shift over time.

What to watch

Tom Newman's arrival as CEO Designate on 5 October 2026 is the next dated milestone, followed by the end of Chemring's financial year on 31 October and his formal appointment as Group CEO on 1 January 2027. Full-year results will show whether the Board's unchanged expectations have been met and how second-half margins compare with the first half.

Other areas to monitor include the ramp-up of the Chicago facility, commissioning in Scotland, the next phase in Norway, progress on UK orders, and further counter-drone sales at Roke. Movements in net debt as the capex programme continues will also be closely followed.

Conclusion

Chemring enters the second half of its financial year with a record order book, most of its expected 2026 revenue already secured and investment under way to expand energetics capacity. Against that, profits and margins fell in the first half, debt has risen and a leadership change is approaching. How effectively the group converts strong demand into improved profitability will determine how its position in the defence sector develops.